I 

109TH CONGRESS 

1ST SESSION H. R. 2065

To establish formally the United States Military Cancer Institute, to require 

the Institute to promote the health of members of the Armed Forces 

and their dependents by enhancing cancer research and treatment, to 

provide for a study of the epidemiological causes of cancer among various 

ethnic groups for cancer prevention and early detection efforts, and 

for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 3, 2005

Mr. YOUNG of Florida introduced the following bill; which was referred to the 

Committee on Armed Services 

A BILL

To establish formally the United States Military Cancer Institute, to require the Institute to promote the health 

of members of the Armed Forces and their dependents 

by enhancing cancer research and treatment, to provide 

for a study of the epidemiological causes of cancer among 

various ethnic groups for cancer prevention and early 

detection efforts, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 2065 IH 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘United States Military 

3 Cancer Institute Act of 2005’’. 

4 SEC. 2. UNITED STATES MILITARY CANCER INSTITUTE. 

5 (a) ESTABLISHMENT.—

6 (1) IN GENERAL.—There is established in the 

7 Uniformed Services University of the Health 

8 Sciences (USUHS) the United States Military Can9 cer Institute (USMCI). 

10 (2) SCIENTISTS.—The staff of the Institute 

11 shall include clinical and basic scientists in the De12 partment of Defense who have an expertise in re13 search, patient care, and education relating to oncol14 ogy and who meet applicable criteria for participa15 tion in the Institute. 

16 (3) COMPONENTS.—The components of the In17 stitute shall include military treatment and research 

18 facilities that meet applicable criteria and are des19 ignated by the Director of the Institute as divisions 

20 of the Institute. 

21 (b) RESEARCH.—

22 (1) RESEARCH SUBJECTS.—The Institute shall 

23 carry out research studies on the following subjects: 

24 (A) The epidemiological features of cancer, 

25 including assessments of both the carcinogenic 

26 effect of genetic and environmental factors and 
3

•HR 2065 IH 

1 the disparities in health, inherent or common, 

2 among populations of various ethnic origins. 

3 (B) The prevention and early detection of 

4 cancer. 

5 (C) Basic, translational, and clinical inves6 tigation matters relating to the subjects de7 scribed in subparagraphs (A) and (B). 

8 (2) COMPLEMENTARY RESEARCH ON ONCO9 LOGIC NURSING.—The research studies under para10 graph (1) shall include complementary research on 

11 oncologic nursing. 

12 (c) COLLABORATIVE RESEARCH.—The Institute shall 

13 carry out the research studies under subsection (b) in col14 laboration with other cancer research organizations and 

15 entities, as selected by the Director of the Institute for 

16 purposes of research studies. 

17 (d) REPORTS.—

18 (1) IN GENERAL.—Not later than one year 

19 after the date of the enactment of this Act, and an20 nually thereafter, the Director of the Institute shall 

21 submit to the President of the USUHS a report on 

22 the results of the research studies carried out under 

23 subsection (b). 

24 (2) TRANSMISSION OF REPORT.—Not later than 

25 60 days after the receipt of a report under para-
4

•HR 2065 IH 

1 graph (1), the President of the USUHS shall trans2 mit such report to Congress.

Æ